Fingerprint
Dive into the research topics of 'Direct and complement dependent cytotoxicity in CLL cells from patients with high-risk early-intermediate stage chronic lymphocytic leukemia (CLL) treated with alemtuzumab and rituximab'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically